U.S. Cannabidiol (CBD) Market, By CBD Type (Hemp, Marijuana), Product Type (CBD Oil, CBD Concentrates, CBD Isolates, Others), CBD Category (Full-Spectrum, Broad Spectrum), Nature (Organic, Inorganic), Grade (Food, Therapeutic), Application (Food, Beverages, Pharmaceuticals, Topicals, Tincture, Dietary Supplements, Others), Market Trends and Forecast to 2029.
Market Analysis and Insights
The U.S. cannabidiol (CBD) market is expected to gain significant growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 28.6% in the forecast period of 2022 to 2029 and is expected to reach USD 13,655.70 million by 2029. The major factor driving the growth of the cannabidiol market is the growing demand for CBD in health & fitness, improving government approvals & regulations, therapeutic properties of CBD oil, and consumers’ shift towards legally purchasing cannabis, for medical as well as recreational use.
Cannabidiol (CBD) is obtained from the cannabis plant, which can be used for various applications. Also, commonly found in hemp and marijuana plants, the extract is also used for research and development proficiencies. The extract consists of 40% of the entire plant, and does not have any harmful effects on humans. Cannabidiol (CBD) has various health benefits, such as treating health disorders such as Parkinson's disease, Alzheimer’s, and multiple sclerosis. It is effective against stress, reduces acne, and alleviates cancer-related symptoms; thus, it is used in many pharmaceutical applications.
Cannabidiol derived from hemp is anticipated to witness rapid growth owing to increasing demand from the pharmaceutical sector and rising awareness among consumers regarding health.
The increasing acceptance of refined CBD products combined with the increasing legalization of marijuana and marijuana-derived products for various medical applications is expected to drive the growth of the marijuana CBD market.
The U.S. cannabidiol (CBD) market report provides details of market share, new developments, and the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, products approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.
2022 to 2029
2020 (Customizable to 2019 - 2014)
Revenue in USD Million
By CBD Type (Hemp, Marijuana), Product Type (CBD Oil, CBD Concentrates, CBD Isolates, Others), CBD Category (Full-Spectrum, Broad Spectrum), Nature (Organic, Inorganic), Grade (Food, Therapeutic), Application (Food, Beverages, Pharmaceuticals, Topicals, Tincture, Dietary Supplements, Others)
Market Players Covered
Cresco Labs., EcoGen Biosciences, Canopy Growth Corporation, The Valens Company, Open Book Extracts, Groff North America Hemplex, Healthy Food Ingredients, LLC, KND Labs, Socati Corp., and Swayer Labs.
Cannabidiol (CBD) is obtained out from the cannabis plant, which can be used for a wide range of applications. Also, commonly found in hemp and marijuana plants, the extract is also used for research and development proficiencies. The extract consists of forty percent of the entire plant and it doesn’t have any harmful effects on the humans. Cannabidiol (CBD) has various health benefits such as treating health disorders like Parkinson’s disease, Alzheimer and multiple sclerosis. Cannabidiol (CBD) is effective against stress, reduces acne and alleviates cancer-related symptoms and thus, is used in many pharmaceutical applications
US Cannabidiol (CBD) Market Dynamics
- Increasing demand for CBD in health and fitness
CBD-based oils also help relieve delayed onset muscle soreness and exercise-induced muscle damage, which naturally occurs after physical activity due to microscopic damage to muscle fibers. Its healing properties reduce muscle pain, body aches, and inflammation. CBD offers numerous benefits as it induces sleep and reduces inflammation, a perfect combination for muscle recovery. If the person is anxious during the gym or any sought of games, CBD can help calm nerves and provide confidence. Thus, widespread use of CBD products and changing consumer opinion have increased the adoption of CBD products, which may propel the demand for the U.S. cannabidiol (CBD) market.
- Improving government approvals and regulations for CBD products
The newfound government policies approved by the Food and Drug Administration (FDA) and the U.S. Department of Agriculture (USDA) support the industry, lower cannabidiol production costs, and upscaling the manufacturing infrastructure and expertise. This is expected to create fierce competition for the U.S. CBD companies, which is expected to drive the U.S. cannabidiol (CBD) market over the coming years.
- Therapeutic properties of CBD oil
Clinical trials finished on CBD have portrayed its efficacy in treating various forms of epilepsy. Based on this development, countries, including the U.S., are seeking to incorporate CBD-based therapeutics, significantly generating demand for the market. Therefore, CBD offers a range of therapeutic benefits, from treating serious problems such as epilepsy to the treatment of anxiety and stress. This is expected to boost the demand for CBD-based products further and, in turn, amplify the growth in the U.S. cannabidiol (CBD) market.
- Increasing investments in the development of new CBD based products
The increasing demand has increased the number of trials to study the impact of CBD on certain health conditions, which is expected to develop new products, in turn providing an opportunity for the rise in the demand in the forthcoming years. Furthermore, many companies procure CBD oils in bulk and manufacture CBD-infused products. In addition, numerous health and wellness retailers are offering CBD-based products, such as Rite Aid, CVS Health, and Walgreens Boots Alliance.
- Growing medical applications of CBD
Medical CBD is probably most commonly associated with managing pain related to arthritis and cancer. CBD has also shown effective results in the treatment of topical pain. CBD's ability to cure pain relief makes it a promising replacement for opioids. CBD has also proven its efficacy in treating complex motor disorders, including epilepsy, spasticity and dystonia, and Dravet syndrome. CBD has also shown promising results in treating dementia, cannabis dependence, tobacco and opioid dependence, psychoses and schizophrenia, general social anxiety, post-traumatic stress disorder, anorexia nervosa, attention-deficit hyperactivity disorder, Parkinson's disease, and Tourette's disorder.
- High cost of CBD products
Additionally, hemp requires more time and labor to grow, and farmers need to inspect their crop closely as it grows. Furthermore, once it is harvested, extracting the cannabidiol is a difficult and expensive process. The processors and extractors of CBD either use ethanol or supercritical carbon dioxide (CO2 extraction) in their extraction process. The extraction and refinement process requires special machinery and takes a long time, which also drives up the CBD cost. Thus, all these factors add up to the costs of CBD products, making them much more costly than other products, which is likely to restrain the market's demand.
- Availability of counterfeit and synthetic products in the market
Such substitute products offer a cheaper variety to consumers while affecting the demand for CBD products. However, owing to such cases of mislabeling and utilization of synthetic marijuana, the FDA worked actively and sent warning letters to many companies after testing their products where no traces of CBD were found in them. FDA does not approve these products for the diagnosis, cure, mitigation, treatment, or prevention of any disease, and consumers should be aware while purchasing and using any such products. Yet, the availability of cheap synthetic alternatives to CBD may hinder the market demand.
- Side effects associated with CBD oil
Further, dietary supplements that contain CBD and a blend of herbal ingredients may not be safe for everyone, as many herbs have the potential to interact with commonly prescribed medications. All these side effects may vary from person to person as minor side effects for some may prove to be serious for others. This may challenge the increasing demand for CBD products in the U.S. cannabidiol (CBD) market.
- Barriers in terms of marketing of CBD
Apart from this, the regulations regarding approval and standardization of CBD-based products are another barrier, which caused hindrance in the market growth. There have been certain regulations that do not allow the sales of these products in the international market and prevent trade activities between the countries. All these barriers are anticipated to challenge the growth of the U.S. cannabidiol (CBD) market.
COVID-19 had a Minimal Impact on U.S. Cannabidiol (CBD) Market
COVID-19 impacted various manufacturing industries in the year 2020-2021 as it led to the closure of workplaces, disruption of supply chains, and restrictions on transportation. In addition, due to supply chain disruptions in the U.S., the supply of other raw materials has been limited, which is disrupting the manufacturing, and in turn, the supply chain of CBD consumer health products. Amidst the COVID-19 outbreak, investors and manufacturers are pulling back the production and reconsidering investments. This is expected to act as a key headwind for the growth of the U.S. Cannabidiol (CBD) market. However, CBD block SARS-CoV-2 infection at the early stages of infection, and CBD administration is associated with a lower risk of SARS-CoV-2 infection in humans. In addition, the rising acceptance and use of products due to government approvals is a major factor expected to boost the production of CBD-infused products. Due to its healing properties, the demand for cannabidiol (CBD) for health and wellness purposes is high, which is the major factor driving the market growth.
- In March 2022, Cresco Labs and Columbia Care Inc. entered into a definitive arrangement agreement to acquire all of the issued and outstanding shares of Columbia Care. Under the terms of the Agreement, shareholders of Columbia Care will receive 0.5579 of a subordinate voting share of Cresco Labs for each Columbia Care common share.
U.S. Cannabidiol (CBD) Market Scope
U.S. cannabidiol (CBD) market is categorized based on CBD type, product type, CBD category, grade, application, and nature. The growth amongst these segments will help you analyze major growth segments in the industries and provide the users with a valuable market overview and market insights to make strategic decisions to identify core market applications.
On the basis of CBD type, the U.S. cannabidiol (CBD) market is segmented into hemp and marijuana.
- CBD Oil
- CBD Isolates
- CBD Concentrates
On the basis of product type, the U.S. cannabidiol (CBD) market is segmented into CBD oil, CBD isolates, CBD concentrates, and others.
- Broad Spectrum
On the basis of CBD category, the U.S. cannabidiol (CBD) market is segmented into full-spectrum and broad spectrum.
On the basis of grade, the U.S. cannabidiol (CBD) market is segmented into food and therapeutic
- Dietary Supplements
On the basis of application, the U.S. cannabidiol (CBD) market is segmented into tincture, food, pharmaceuticals, dietary supplements, beverages, topicals and others.
On the basis of nature, the U.S. cannabidiol (CBD) market is segmented into organic and inorganic.
Competitive Landscape and U.S. Cannabidiol (CBD) Market Share Analysis
U.S. cannabidiol (CBD) market competitive landscape provides details by competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to the U.S. cannabidiol (CBD) market.
Some of the prominent participants operating in the U.S. cannabidiol (CBD) market are Socati, Sawyer Labs, Groff North America Hemplex, Valens Company Inc., Canopy Growth Corporation, Cresco Labs, EcoGen Biosciences, Healthy Food Ingredients, KND Labs, and Open Book Extracts among others.
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global Vs Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.